A description of this cancer from Myeloma Central explains, “Multiple myeloma (MM) is a chronic (long-lasting) and progressive (worsening over time) disease that requires a long-term plan to help manage it”. The 5-year survival rate of multiple myeloma is 49%, meaning that 49% of patients live for at least 5 years after the cancer is found. The disease also grows worse over time, making it extremely difficult to deal with the longer it progresses. Another way multiple myeloma is described is from the Multiple Myeloma Research Foundation (or MMRF) which says “Multiple myeloma is a hematological (blood) cancer that develops in the plasma cells found in the soft, spongy tissue at the center of your bones, called bone marrow”. Multiple myeloma is categorized as a blood cancer because it develops in the plasma cells found in the bone marrow, which is where blood cells are produced. This also means that when the cancer grows, it attacks the bones themselves and breaks them down causing the patient extreme pain.
A description of this cancer from Myeloma Central explains, “Multiple myeloma (MM) is a chronic (long-lasting) and progressive (worsening over time) disease that requires a long-term plan to help manage it”. The 5-year survival rate of multiple myeloma is 49%, meaning that 49% of patients live for at least 5 years after the cancer is found. The disease also grows worse over time, making it extremely difficult to deal with the longer it progresses. Another way multiple myeloma is described is from the Multiple Myeloma Research Foundation (or MMRF) which says “Multiple myeloma is a hematological (blood) cancer that develops in the plasma cells found in the soft, spongy tissue at the center of your bones, called bone marrow”. Multiple myeloma is categorized as a blood cancer because it develops in the plasma cells found in the bone marrow, which is where blood cells are produced. This also means that when the cancer grows, it attacks the bones themselves and breaks them down causing the patient extreme pain.